Strategy. Science. Success.

The Big Picture provides the strategic context for the issues that drive your commercial decisions. The disruptive big ideas, the geopolitical context re-writing the rule book, the opposing viewpoints that clarify the right path — these are the discussions that will make the future of biotech.

The intersection of capital, strategy, and deal-making. The Business of Biotech track brings together the decision-makers shaping investment flows, M&A activity, and global partnerships across the industry. From shifting capital trends and the rise of AI to the growing influence of Eastern markets, this track is where biotech leaders, investors, and advisors define what’s next.

Key sessions include:

• Voices from the IPO Class of ’25/’26: What’s Next?
• The State of Early-Stage Investment in Biotech
• Scaling Success: The Dynamics of Late-Stage Investment in Biotech
• The 'Unpacking the Deal' Series - fireside chats with some of this year's biggest dealmakers

The Regulatory Strategy track delves into the fundamental transformation of Europe’s regulatory and innovation ecosystem, exploring how frameworks like the General Pharmaceutical Legislation (GPL) and the Biotech Act, are reshaping the competitive landscape. By drawing comparisons with global regulatory frameworks in key areas, this regulatory track offers actionable insights and suggestions to streamline your regulatory strategy. Join top policymakers, industry leaders, and experts to uncover how regulatory frameworks can become a competitive advantage and drive innovation.

Key sessions include:

• Accelerating Innovation and Market Exclusivity Through Regulatory Incentives
• Mastering the Shifting Regulatory Landscape: Leveraging the Biotech Act for Innovation and Global Success
• AI Regulations: Driving Innovation While Navigating Compliance

This is where science meets strategy. The Therapeutic Insights track spotlights the most exciting areas of innovation—from neuroscience and rare diseases to women’s health and longevity—and the partnerships and models accelerating them forward. Align your strategy with cutting-edge science and high-value therapeutic areas, while engaging the biotech and pharma leaders driving the next wave of breakthroughs. Discover the science driving breakthrough therapies and the biopharma partnerships that are redefining what is possible.

Key topics include:

• Cardiometabolic innovations beyond GLP-1 – Where are we now?
• Networks or neurons: What’s next in CNS dealmaking?
• Immunology under the microscope: New frontiers
• Radioligand therapy: Where we've progressed and what matters next

The Biomanufacturing Strategies track aims to accelerate company success through innovation and strategic partnerships. The sessions in this track highlight the vital role of partnerships in the development, manufacturing, and commercialization of cutting-edge therapies. Future-focused discussions will address challenges, opportunities, and solutions in the acceleration of drug development timelines and the pursuit of enhanced manufacturing excellence.

Featured topics include:

• Technology Transfer Excellence
• Strategic Manufacturing Models for Biotech Startups
• Supply Chain Resilience & Business Continuity
• Global Manufacturing Strategy for Biopharma: Navigating regulations, site selection, and supply chain optimization

Biotech is no longer built within four walls—it’s built across global ecosystems of partners, platforms, and emerging hubs. The Ecosystem Innovation track explores how innovation is being enabled by clusters, service providers, infrastructure, and new partnership models worldwide. From next-generation incubators and rising biotech regions to the growing role of CROs, CDMOs, and data platforms as strategic partners, this track showcases how the industry is evolving beyond traditional models.

Explore the power of partnering as biotech blooms beyond the usual hubs. Key Topics include:

• Evolution of biotech hubs around the globe
• Role of next-generation incubators in fostering innovation
• Rise of emerging marketing and their impact on the industry
• New innovations in developing biotech clusters

The Clinical Development Strategy track provides actionable strategies to streamline trial processes, navigate emerging markets, and leverage cutting-edge technologies like AI to drive efficiency and innovation. Attendees will gain insights into fostering global collaboration, building strong partnerships with CROs, funders, and innovators, and overcoming regulatory challenges to deliver impactful results. This track empowers stakeholders to expand their reach, collaborate effectively, and lead the future of clinical trials.

Sessions include:

• Expanding the Global Footprint: Opportunities and Challenges in Emerging Markets
• Mission-Driven Investments: Balancing Capital and Clinical Impact
• AI in Clinical Trials: Transforming Operations and Accelerating Development